Amid fluctuating global markets, with the Hang Seng Index showing a notable rise last week, investors are keenly observing trends and opportunities in Hong Kong's vibrant economy. In this context, growth companies with high insider ownership present a compelling narrative, as such firms often signal strong confidence from those closest to the business in its prospects and governance.
YANTAI, China, June 3, 2024 /PRNewswire/ RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, presented the results of the first-in-human, single-arm, open-label, multi-center
/PRNewswire/ RemeGen Co. Ltd. ("RemeGen" or "the Company") (9995.HK, 688331.SH), a commercial-stage biotechnology company, recently announced significant.
RemeGen's Telitacicept (RC18) Granted Fast Track Designation by United States FDA for Treatment of Primary Sjögren's Syndrome streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.